Nephros, Inc.NEPHNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+4.5%
5Y CAGR+2.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.5%/yr
vs +9.9%/yr prior
5Y CAGR
+2.4%/yr
Consistent
Acceleration
-5.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.34M | +18.6% |
| 2024 | $8.72M | -12.8% |
| 2023 | $10.00M | +10.3% |
| 2022 | $9.07M | +2.0% |
| 2021 | $8.88M | -3.3% |
| 2020 | $9.19M | -0.6% |
| 2019 | $9.24M | +48.6% |
| 2018 | $6.22M | +37.6% |
| 2017 | $4.52M | +8.5% |
| 2016 | $4.16M | - |